Boston Scientific Corp (BSX)

TheFly reported on April 13 that Mizuho reduced its price target on BSX to $90 from $115 while maintaining an Outperform rating.

The first quarter of this year has seen a great deal of volatility in the equity markets. The S&P 500 fell into correction territory before rising again after first soaring to all-time highs.

Last week, volatility-linked and systematic strategies sold $24 billion worth of stocks, Reuters reported on April 8, 2026.

In this article, we will look at oversold names that offer double-digit ROE growth for investors across sectors.

On April 7, Joseph Amato of Neuberger Berman joined CNBC's 'Closing Bell Overtime' to discuss the current market amid volatility and geopolitical concerns, and whether the uncertainty represents a buy...

Oversold stocks are getting a fresh look in 2026, but not simply because they are down.

Stocks hitting 52-week lows tend to draw attention when fear and price action start to outrun fundamentals.

Is BSX a good stock to buy? We came across a bullish thesis on Boston Scientific Corporation on Guardian Research’s Substack. In this article, we will summarize the bulls’ thesis on BSX.

He says he is more risk-averse, at least for the near-term, and stated that everybody on Wall Street is trying to be a military expert in this fog of war, when actually, even the military experts cannot...